Stay updated on Pembrolizumab in EOC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in EOC Clinical Trial page.

Latest updates to the Pembrolizumab in EOC Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe revision label on the page was updated to v3.6.4, signaling a small patch or update to the documented content.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedPage revision updated to v3.6.3, indicating a small update to the page's underlying template/assets; no study content changes are reflected in this update.SummaryDifference0.1%

- Check36 days agoChange DetectedThe page's revision label at the bottom was updated from Revision: v3.6.0 to Revision: v3.6.2, signaling a minor metadata update to the study record page.SummaryDifference0.1%

- Check50 days agoChange DetectedThe study page now indicates the trial is no longer recruiting. New navigation/help sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and the Intervention/Treatment heading formatting was updated with a new page revision noted as v3.6.0.SummaryDifference0.5%

- Check58 days agoChange DetectedThe page's revision tag was updated to v3.5.5, indicating a small internal update to the page's documentation or rendering.SummaryDifference0.1%

- Check79 days agoChange DetectedAdded a new page revision label 'Revision: v3.5.4' and removed the previous 'Revision: v3.5.3', indicating an update to the page metadata. The update appears to reflect record maintenance rather than changes to the study details.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in EOC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in EOC Clinical Trial page.